Advances of Artificial Intelligence in the Management of Patients with Central Nervous System Tumors
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: closed (15 July 2022) | Viewed by 8211
Special Issue Editors
Interests: neuroimaging; brain tumors, gliomas; machine learning; intraoperative ultrasound; elastography
Special Issue Information
Dear Colleagues,
We are living at the beginning of a new era in precision medicine. Central nervous system neoplasms represent a significant challenge due to their great heterogeneity and pathophysiological characteristics. Nevertheless, thanks to advances in data processing techniques in recent years, we are increasingly close to providing management adapted to particular circumstances of our patients.
In recent years, advanced neuroimaging techniques, such as diffusion tensor imaging (DTI), dynamic susceptibility contrast (DSC), dynamic contrast-enhanced imaging (DCE), MR spectroscopy, and magnetic resonance elastography (MRE) provided valuable qualitative and quantitative information about morphology and function that can be used as a biomarkers in brain tumors.
On the other hand, the molecular characterization of tumors is enhanced with current genetic sequencing techniques and transcriptomic and proteomic analysis.
A large amount of data from advanced image analysis and new molecular techniques pose a challenge for processing and interpretation. Nevertheless, artificial intelligence, understood as any method that allows the imitation of human intelligence, allows significant advances in neuro-oncology. Its application allows the performance of complex tasks related to diagnosis, segmentation, histopathological diagnosis, tracking tumor development, classification, and predictions of outcome. Thus, the classification and prediction results generated by IA can be applied in daily clinical practice.
We welcome submissions of research papers providing evidence for the development and application of techniques based on artificial intelligence related to managing CNS tumors.
Dr. Santiago Cepeda
Dr. Sergio García-García
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence
- brain tumors
- machine learning
- deep learning